Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $18.38M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Cara Therapeutics USD 43.75M 4.8M Jun/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
Cronos Group USD 1.2B 18.73M Dec/2025
RedHill Biopharma USD 18.38M 332K Jun/2025